COMMUNITY ACQUIRED PNEUMONIA
Clinical trials for COMMUNITY ACQUIRED PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new COMMUNITY ACQUIRED PNEUMONIA trials appear
Sign up with your email to follow new studies for COMMUNITY ACQUIRED PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep pneumonia patients out of hospital
Disease control TerminatedThis study tested whether adding an experimental drug called silmitasertib to standard care could help adults with pneumonia caused by COVID-19 or the flu. The goal was to see if the combination treatment could prevent patients from getting worse and needing to go to the hospital…
Matched conditions: COMMUNITY ACQUIRED PNEUMONIA
Phase: PHASE2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Scientists probe immune System's role in deadly pneumonia complications
Knowledge-focused TerminatedThis study aimed to understand why some cases of severe pneumonia get worse and lead to a life-threatening lung condition called ARDS, despite antibiotic treatment. Researchers compared blood and lung fluid samples from about 150 ICU patients with pneumonia to 50 ICU patients wit…
Matched conditions: COMMUNITY ACQUIRED PNEUMONIA
Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC